Electrochemiluminescence (ECL) has a great promise for biological applications, especially when combined with microfluidics. Here, we report the first integration of ECL with digital microfluidics. ECL cells were fabricated into the ITO-coated top plates of DMF devices, and the new DMF-ECL system was validated by an oligonucleotide hybridization assay, using magnetic particles bearing 21-mer, deoxyribose analogues of the complement to the microRNA, miRNA-143. The system can specifically detect single nucleotide mismatches and has a limit of detection of 1.5 femtomoles. The system can also detect miRNA-143 in cancer cell lysates, allowing for the discrimination between the MCF-7 and MDA-MB-231 cell lines.
INTRODUCTION
Electrochemiluminescence (ECL), a phenomenon in which electrical energy excites analytes that subsequently emit photons, has attracted tremendous attention as a detection system for micro-scale chemical analysis [1] because of its (a) low background optical signal, (b) 3-6 orders of magnitude dynamic range, (c) great control over non-separation heterogeneous bioassays, and (d) high sensitivity. ECL detection has never before been integrated with digital microfluidics (DMF), a technique which is capable of implementing complex protocols involving mixing, magnetic particle separation from supernatant, and washing. Here, we report a DMF-ECL system applied to a magnetic particle-based nucleic acid hybridization assay using sample volumes of ~1.8 µL (Fig. 1) . The system was validated by application to analysis of microRNA (miRNA) expression levels that are associated with cancer [2] .We propose that the coupling between DMF and ECL represents a useful new addition to the analyst's toolbox, with particular utility in the emerging area of microRNA analysis.
EXPERIMENTAL
ECL cells, each bearing two ITO working electrodes (WEs) and one Ag/Au/ITO counter/pseudoreference electrode (CE/RE), were patterned in the middle of a DMF top-plate (25 x 75 mm) by photolithography using methods similar to those reported for electrochemical analysis [3] . Apertures through the Teflon-AF coating were opened using a lift-off procedure, forming two sets of electroanalytical electrodes for ECL (Fig. 1) . DMF-ECL cells were characterized by cyclic voltammetry on ITO WE vs Ag/Au/ITO CE/RE using a 1:1 mixture of 200 µM Ru(Phen) 3 2+ and 20 mM tripropylamine (TPA) in PBS buffer at a scan rate of 100 mV/s. ECL was generated at ITO by applying 1.5 V between the WE and the CE/RE using the same reagent mixture.
A magnetic particle-based nucleic acid hybridization assay was developed and implemented on the new DMF-ECL platform. Magnetic particles were modified via avidin-biotin chemistry with a 21-mer DNA analogue of the complement to miRNA-143. The particles were exposed to a droplet containing one or more DNA target molecules (fully matched 'ds-143', single mismatch '143-m1', double mismatch '143-m2' or noncomplementary 'nc-145') as shown in Table 1 . The ECL for hybridized sequences was recorded after hybridization, intercalation, washing, and mixing with Ru(Phen) 3 2+ and TPA. The method was applied to standards in buffer, as well as cell-density-matched lysates (equiv. to 10 6 cells/mL) of MCF-7 and MDA-MB-231 cells. Average signal levels were compared by students t-Test.
Table 1. Oligonucleotide sequences

RESULTS AND DISCUSSION
The new DMF-ECL system was characterized by electrochemistry; Figure 2A 2+ and TPA, reaching a plateau at 1.4-1.5 V. A seven step protocol, depicted in Figure 2B , was designed and optimized to quantify the level of analyte hybridization to an immobilized probe sequence. Figure 2C is a typical ECL response after implementing the steps indicated in Fig. 2B ; the maximum observed response was recorded for quantitation.
A synthetic deoxyribose analogue of miRNA-143 (ds-143) was used as a model analyte while sequences bearing single-(143-m1) and double-(143-m2) nucleotide mismatches and a fully noncomplementary oligonucleotide (nc-145) were used to test the specificity of the system. Figure 3A shows the relative ECL responses of the various sequences. It is evident that single and double nucleotide mis- matched sequences can be distinguished from fully complementary sequence (p = 0.002, p = 0.001 respectively) while the signal from the fully non-complementary sequence cannot be distinguished from that of the blank (p = 0.2). Figure 3B is a calibration curve for the target analyte (ds-143), with a limit of detection of = 1.5 femtomoles. Finally, the new DMF-ECL method was applied to evaluate miRNA-143 expression in two cancer cell lines. As shown in Figure 3C , the signals observed for both MDA-MB-231 and MCF-7 are greater than that of the background, and the signal observed for MDA-MB-231 is significantly lower than that observed for MCF-7 (p = 0.03). This observation is consistent with the understanding that miRNA-143 expression is down-regulated in some aggressive forms of cancer [4] , and that MDA-MB-231 cells are the more aggressive (in terms of propensity to metastasize) of the two lines evaluated here [5] .
CONCLUSION
We report the first integration of ECL detection with DMF. The method was validated by application to magnetic particle-based nucleic acid hybridization assays using sample volumes of 1.8 µL. The system can specifically detect single nucleotide differences in 21-mer deoxyribose analogues of miRNA-143, with a limit of detection of 1.5 femtomoles. Moreover, the system is capable of detecting miRNA-143 in breast cancer cell lysates, allowing for the discrimination between cell phenotype.
